Psicobiología y Metodología en Ciencias del Comportamiento
Departamento
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (29)
2024
-
Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient
International Journal of Drug Policy, Vol. 130
-
Dysregulation of Plasma Growth Factors and Chemokines in Cocaine Use Disorder: Implications for Dual Diagnosis with Schizophrenia and Antisocial Personality Disorder in an Exploratory Study
Neuropsychobiology, Vol. 83, Núm. 2, pp. 73-88
-
Re-exploring the relationships of humor styles with dark triad and self-esteem using structural equation modelling
Personality and Individual Differences, Vol. 221
-
Resting State Electrophysiological Profiles and Their Relationship with Cognitive Performance in Cognitively Unimpaired Older Adults: A Systematic Review
Journal of Alzheimer's Disease, Vol. 100, Núm. 2, pp. 453-468
-
Understanding the Co-occurrence of Gambling Disorder and Problematic Pornography Use: Exploring Sociodemographic and Clinical Factors
Journal of Gambling Studies, Vol. 40, Núm. 3, pp. 1295-1314
2023
-
Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder
Drug and Alcohol Dependence, Vol. 245
-
Author Correction: Association of hyperuricemia and gamma glutamyl transferase as a marker of metabolic risk in alcohol use disorder (Scientific Reports, (2020), 10, 1, (20060), 10.1038/s41598-020-77013-1)
Scientific Reports
-
Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease
Journal of Neuroimaging, Vol. 33, Núm. 6, pp. 953-959
-
Sex differences in the comorbidity of patients seeking a first treatment for Alcohol Use Disorder
International Journal of Mental Health and Addiction
2022
-
Using a robotic exoskeleton at home: An activity tolerance case study of a child with spinal muscular atrophy
Journal of Pediatric Nursing, Vol. 67, pp. e71-e78
-
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
Biomedicines, Vol. 10, Núm. 5
2021
-
Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder
Scientific Reports, Vol. 11, Núm. 1
-
The role of premorbid iq and age of onset as useful predictors of clinical, functional outcomes, and recovery of individuals with a first episode of psychosis
Journal of Clinical Medicine, Vol. 10, Núm. 11
2020
-
Towards a common metric for assessing heroin-dependent patient satisfaction with medications: Testing methadone and buprenorphine-naloxone
Drug and Alcohol Dependence, Vol. 212
2019
2018
-
A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers
Drug and Alcohol Dependence, Vol. 187, pp. 278-284
-
Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study
European Archives of Psychiatry and Clinical Neuroscience, Vol. 268, Núm. 7, pp. 699-711
2017
-
Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service
Journal of Psychoactive Drugs, Vol. 49, Núm. 4, pp. 306-315
-
Plasma chemokines in patients with alcohol use disorders: Association of CCL11 (Eotaxin-1) with psychiatric comorbidity
Frontiers in Psychiatry, Vol. 7, Núm. JAN
-
Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence
Addiction Biology, Vol. 22, Núm. 5, pp. 1366-1377